Search
for
Sort by
Research 61–90 of 1000+
- Severe cutaneous adverse reactions to drugs
- Safety of dermatologic medications in pregnancy and lactation
- Drugs and Hair Loss
- Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Alopecia induced by tumour necrosis factor-alpha antagonists: description of 52 cases and disproportionality analysis in a nationwide pharmacovigilance database
- Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
- Alopecia universalis during treatment with leflunomide and adalimumab - Case report
- Trichorrhexis nodosa: a distinctive presentation after tumour necrosis factor-α inhibitor therapy
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Novel therapies for alopecia areata: The era of rational drug development
- Innovative Therapeutics in Pediatric Dermatology
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regression
- Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives
- Ottawa, Ontario, Canada, February 13–16, 2013
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- FDA declines approval of testosterone drug for third time
- Current systemic treatment strategies for hidradenitis suppurativa
- British Association of Dermatologists centenary year: standing on the shoulders of giants
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- A 29-Year-Old Woman with Treatment-Resistant Dandruff
- Alopecia Universalis: an extremely rare but probable adverse effect of adalimumab
- PSS33 REAL-LIFE DOSING OF BIOLOGICS IN PLAQUE PSORIASIS—A GERMAN SURVEY
- Adverse Effects and Drug Interactions of Biologic Agents
- Janus kinase inhibitors in dermatology: A systematic review
- 560 Isolation of an “early” transit amplifying keratinocyte population in interfollicular human epidermis: a role for CD271 receptor
- Management of a Refractory EIF3E-RSPO2 Fusion Positive Pilomatrical Cancer Patient with Encyclopedic Tumor Analysis Guided Treatment